HIGHLIGHTS
- who: Hiroaki Takahashi from the Division of Clinical Pharmaceutics and Pharmacy Practice, Department of Clinical Pharmacy, School of Pharmacy, Iwate Medical University, u20111u2011, Idaidori, Yahabau2011cyo, Shiwau2011gun, Iwate, u20113694, Japan have published the paper: Effect of risk factors for acneiform rash induced by anti-epidermal growth factor receptor antibody drugs on survival: a retrospective observational study, in the Journal: (JOURNAL)
- what: This study investigated the relationship between risk factors for anti-EGFR antibody drug-induced acneiform rash and survival probability in colorectal cancer patients as well as effects of drug withdrawal dose reduction or treatment discontinuation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.